Copyright Reports & Markets. All rights reserved.

Global Nausea Medicine Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Nausea Medicine

      • 1.1 Definition of Nausea Medicine
      • 1.2 Nausea Medicine Segment by Type
        • 1.2.1 Global Nausea Medicine Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Antacids
        • 1.2.3 Antagonists
        • 1.2.4 Anti-Anxiety Drugs
        • 1.2.5 Steroids
        • 1.2.6 Cannabinoids
      • 1.3 Nausea Medicine Segment by Applications
        • 1.3.1 Global Nausea Medicine Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinics
        • 1.3.4 Pharmaceutical Companies
      • 1.4 Global Nausea Medicine Overall Market
        • 1.4.1 Global Nausea Medicine Revenue (2014-2025)
        • 1.4.2 Global Nausea Medicine Production (2014-2025)
        • 1.4.3 North America Nausea Medicine Status and Prospect (2014-2025)
        • 1.4.4 Europe Nausea Medicine Status and Prospect (2014-2025)
        • 1.4.5 China Nausea Medicine Status and Prospect (2014-2025)
        • 1.4.6 Japan Nausea Medicine Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Nausea Medicine Status and Prospect (2014-2025)
        • 1.4.8 India Nausea Medicine Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Nausea Medicine
      • 2.3 Manufacturing Process Analysis of Nausea Medicine
      • 2.4 Industry Chain Structure of Nausea Medicine

      3 Development and Manufacturing Plants Analysis of Nausea Medicine

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Nausea Medicine Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Nausea Medicine
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Nausea Medicine Production and Capacity Analysis
      • 4.2 Nausea Medicine Revenue Analysis
      • 4.3 Nausea Medicine Price Analysis
      • 4.4 Market Concentration Degree

      5 Nausea Medicine Regional Market Analysis

      • 5.1 Nausea Medicine Production by Regions
        • 5.1.1 Global Nausea Medicine Production by Regions
        • 5.1.2 Global Nausea Medicine Revenue by Regions
      • 5.2 Nausea Medicine Consumption by Regions
      • 5.3 North America Nausea Medicine Market Analysis
        • 5.3.1 North America Nausea Medicine Production
        • 5.3.2 North America Nausea Medicine Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Nausea Medicine Import and Export
      • 5.4 Europe Nausea Medicine Market Analysis
        • 5.4.1 Europe Nausea Medicine Production
        • 5.4.2 Europe Nausea Medicine Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Nausea Medicine Import and Export
      • 5.5 China Nausea Medicine Market Analysis
        • 5.5.1 China Nausea Medicine Production
        • 5.5.2 China Nausea Medicine Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Nausea Medicine Import and Export
      • 5.6 Japan Nausea Medicine Market Analysis
        • 5.6.1 Japan Nausea Medicine Production
        • 5.6.2 Japan Nausea Medicine Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Nausea Medicine Import and Export
      • 5.7 Southeast Asia Nausea Medicine Market Analysis
        • 5.7.1 Southeast Asia Nausea Medicine Production
        • 5.7.2 Southeast Asia Nausea Medicine Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Nausea Medicine Import and Export
      • 5.8 India Nausea Medicine Market Analysis
        • 5.8.1 India Nausea Medicine Production
        • 5.8.2 India Nausea Medicine Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Nausea Medicine Import and Export

      6 Nausea Medicine Segment Market Analysis (by Type)

      • 6.1 Global Nausea Medicine Production by Type
      • 6.2 Global Nausea Medicine Revenue by Type
      • 6.3 Nausea Medicine Price by Type

      7 Nausea Medicine Segment Market Analysis (by Application)

      • 7.1 Global Nausea Medicine Consumption by Application
      • 7.2 Global Nausea Medicine Consumption Market Share by Application (2014-2019)

      8 Nausea Medicine Major Manufacturers Analysis

      • 8.1 Merck
        • 8.1.1 Merck Nausea Medicine Production Sites and Area Served
        • 8.1.2 Merck Product Introduction, Application and Specification
        • 8.1.3 Merck Nausea Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Sanofi
        • 8.2.1 Sanofi Nausea Medicine Production Sites and Area Served
        • 8.2.2 Sanofi Product Introduction, Application and Specification
        • 8.2.3 Sanofi Nausea Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 TESARO
        • 8.3.1 TESARO Nausea Medicine Production Sites and Area Served
        • 8.3.2 TESARO Product Introduction, Application and Specification
        • 8.3.3 TESARO Nausea Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Roche
        • 8.4.1 Roche Nausea Medicine Production Sites and Area Served
        • 8.4.2 Roche Product Introduction, Application and Specification
        • 8.4.3 Roche Nausea Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Pfizer
        • 8.5.1 Pfizer Nausea Medicine Production Sites and Area Served
        • 8.5.2 Pfizer Product Introduction, Application and Specification
        • 8.5.3 Pfizer Nausea Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 GlaxoSmithKline
        • 8.6.1 GlaxoSmithKline Nausea Medicine Production Sites and Area Served
        • 8.6.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.6.3 GlaxoSmithKline Nausea Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 ANI Pharmaceuticals
        • 8.7.1 ANI Pharmaceuticals Nausea Medicine Production Sites and Area Served
        • 8.7.2 ANI Pharmaceuticals Product Introduction, Application and Specification
        • 8.7.3 ANI Pharmaceuticals Nausea Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served

      9 Development Trend of Analysis of Nausea Medicine Market

      • 9.1 Global Nausea Medicine Market Trend Analysis
        • 9.1.1 Global Nausea Medicine Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Nausea Medicine Regional Market Trend
        • 9.2.1 North America Nausea Medicine Forecast 2019-2025
        • 9.2.2 Europe Nausea Medicine Forecast 2019-2025
        • 9.2.3 China Nausea Medicine Forecast 2019-2025
        • 9.2.4 Japan Nausea Medicine Forecast 2019-2025
        • 9.2.5 Southeast Asia Nausea Medicine Forecast 2019-2025
        • 9.2.6 India Nausea Medicine Forecast 2019-2025
      • 9.3 Nausea Medicine Market Trend (Product Type)
      • 9.4 Nausea Medicine Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Nausea Medicine Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Nausea is an unpleasant, diffuse sensation of unease and discomfort, often perceived as an urge to vomit. While not painful, it can be a debilitating symptom if prolonged, and has been described as placing discomfort on the chest, upper abdomen, or back of the throat.
        Many pharmacologic medications are available for the treatment of nausea. There is no medication that is clearly superior to other medications for all cases of nausea. The choice of antiemetic medication may be based on the situation during which the person experiences nausea. For people with motion sickness and vertigo, antihistamines and anticholinergics such as meclizine and scopolamine are particularly effective. Nausea and vomiting associated with migraine headaches respond best to dopamine antagonists such as metoclopramide, prochlorperazine, and chlorpromazine. In cases of gastroenteritis, serotonin antagonists such as ondansetron were found to suppress nausea and vomiting, as well as reduce the need for IV fluid resuscitation.

        The global Nausea Medicine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Nausea Medicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nausea Medicine market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Nausea Medicine in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Nausea Medicine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Merck
        Sanofi
        TESARO
        Roche
        Pfizer
        GlaxoSmithKline
        ANI Pharmaceuticals
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        by Type
        Antacids
        Antagonists
        Anti-Anxiety Drugs
        Steroids
        Cannabinoids
        by Mode of Administration
        IV
        Tablets
        by Indication
        Gastroesophageal Reflux Disease (GERD)
        Viral Gastroenteritis
        Motion Sickness And Seasickness
        Medication
        Chemotherapy

        Segment by Application
        Hospital
        Clinics
        Pharmaceutical Companies

        Buy now